Where a company has multiple ethical concerns, the total concerns percentage counts this investment once.
The average total concerns of all funds of the same risk profile is weighted by the funds' investment values.
The average total concerns of all managed defensive funds is 1.99%.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the development or release of GMO plants and seeds.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
Where low standards of ethics create harm because of poor culture and inappropriate incentives, inadequate governance and oversight, and incidents of bribery and corruption.
Acquired Credit Suisse in 2023, a bank with very poor governance which aided clients with tax evasion and money laundering. As a result, UBS has inherited ongoing regulatory fines and lawsuits relating to these failures. UBS has also been subject to lawsuits relating to its own manipulation of foreign exchange and interbank rates. It holds a provision of USD $4bn for claims (which may not be sufficient).
Where low standards of ethics create harm because of poor culture and inappropriate incentives, inadequate governance and oversight, and incidents of bribery and corruption.
Wells Fargo is a multinational financial services company which serves millions of customers in 35 countries. They have been involved in significant business ethics scandals for false inflation, cross selling and misleading customers over a period of 2002 to 2016.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the development or release of GMO plants and seeds.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
The Fund invests in a diversified portfolio of actively managed fixed interest securities, cash and derivatives. The predominant investment is in securities issued by governments, supranationals, local authorities, and corporates. The Fund may also invest in emerging market debt, asset backed securities, mortgage backed securities, structured notes, bank loans, high yield securities, mortgage derivatives, preferred securities, unrated securities, cash and cash equivalents, and derivative instruments, including currency hedging instruments.
| Value | $2.33B NZD |
| Period of data report | 31st March 2025 |
| Fund started | 15th March 2017 |
| Total annual fund fees | 0.53% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 0.49% |
| Other management and administration charges | 0.04% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Tony Hildyard |
Currently: Senior Portfolio Specialist (3 years, 6 months)
|
|
Sachin Gupta |
Currently: Executive Vice President and Global Portfolio Manager, Pacific Investment Management Co. (21 years, 3 months)
|
|
Andrew Balls |
Currently: CIO Global Fixed Income, Pacific Investment Management Co. (11 years, 4 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2025 | 3.87% | 3.13% |
| 2024 | 3.43% | 3.51% |
| 2023 | -0.79% | -4.02% |
| 2022 | -2.46% | -3.3% |
| 2021 | 2.15% | 4.87% |
| 2020 | 1.75% | 1.91% |
| 2019 | 2.76% | 2.86% |
| 2018 | 1.94% | 2.8% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Umbs Mortpass 6% 07/54
United States Int Fixed Interest AA+
Tba Umbs Single Family 5%
United States Int Fixed Interest AA+
French 2.75% 02/30
France Int Fixed Interest AA-
Gnma Ii 3.5% 11/54
United States Int Fixed Interest AA+
Umbs Mortpass 6.5% 12/53
United States Int Fixed Interest AA+
Japan Bill Zero 06/25
Japan Cash and Equivalents A1
Kingdom Of 3.55% 10/33
Spain Int Fixed Interest A
United States 4.5% 11/54
United States Int Fixed Interest AA+
Nederlandse 2.5% 09/27
Netherlands Int Fixed Interest AAA
United 4.625% 02/55
United States Int Fixed Interest AA+
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 3.31% |
| New Zealand Fixed Interest | 0.0% | 0.01% |
| International Fixed Interest | 100.0% | 96.68% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 0.0% | 0.0% |
| Listed Properties | 0.0% | 0.0% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
This data is compiled by Mindful Money from the fund information and portfolios
that each
fund has
filed with the Disclose register to 31st March 2025 and Mindful Money
analysis of funds within those portfolios. The list of companies of concern has
been drawn from ratings agencies and public sources, including the Norwegian
Sovereign Fund, NZ Super Fund, Sustainalytics and research organisations.
Please note that companies may breach more than one of these areas of
concern.
The listing of companies of concern is based on definitions used in Mindful Money's
methodology. These definitions may
be different from the exclusions policy and definitions applied by the fund provider.
Mindful Money uses the term Mindful Funds as our standard
for ethical investment and responsible investment. This does not imply that
other funds are unethical or that the fund providers that do not meet these
standards are unethical providers.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the development or release of GMO plants and seeds.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
Where low standards of ethics create harm because of poor culture and inappropriate incentives, inadequate governance and oversight, and incidents of bribery and corruption.
Acquired Credit Suisse in 2023, a bank with very poor governance which aided clients with tax evasion and money laundering. As a result, UBS has inherited ongoing regulatory fines and lawsuits relating to these failures. UBS has also been subject to lawsuits relating to its own manipulation of foreign exchange and interbank rates. It holds a provision of USD $4bn for claims (which may not be sufficient).
Where low standards of ethics create harm because of poor culture and inappropriate incentives, inadequate governance and oversight, and incidents of bribery and corruption.
Wells Fargo is a multinational financial services company which serves millions of customers in 35 countries. They have been involved in significant business ethics scandals for false inflation, cross selling and misleading customers over a period of 2002 to 2016.
Where companies are involved in testing products on animals for cosmetic, personal care, household product, chemical and other uses. We do not include companies which conduct animal testing for pharmaceutical products, medical devices, biotechnology, human food, or pet food.
Where companies are involved in the development or release of GMO plants and seeds.
Where companies are involved in the production or distribution of chemicals which are highly hazardous to human or environmental health including herbicides, pesticides and PFAS.
The Fund invests in a diversified portfolio of actively managed fixed interest securities, cash and derivatives. The predominant investment is in securities issued by governments, supranationals, local authorities, and corporates. The Fund may also invest in emerging market debt, asset backed securities, mortgage backed securities, structured notes, bank loans, high yield securities, mortgage derivatives, preferred securities, unrated securities, cash and cash equivalents, and derivative instruments, including currency hedging instruments.
| Value | $2.33B NZD |
| Period of data report | 31st March 2025 |
| Fund started | 15th March 2017 |
| Total annual fund fees | 0.53% |
| Total performance based fees | 0.0% |
| Manager's basic fee | 0.49% |
| Other management and administration charges | 0.04% |
| Total other charges | 0.0 |
| Total other charges currency | NZD |
|
Tony Hildyard |
Currently: Senior Portfolio Specialist (3 years, 6 months)
|
|
Sachin Gupta |
Currently: Executive Vice President and Global Portfolio Manager, Pacific Investment Management Co. (21 years, 3 months)
|
|
Andrew Balls |
Currently: CIO Global Fixed Income, Pacific Investment Management Co. (11 years, 4 months)
|
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Past annual returns for this fund are after fees and taxes. Please note that higher past returns do not always mean higher future returns.
| Year | Market Average | Fund Annual Return |
|---|---|---|
| 2025 | 3.87% | 3.13% |
| 2024 | 3.43% | 3.51% |
| 2023 | -0.79% | -4.02% |
| 2022 | -2.46% | -3.3% |
| 2021 | 2.15% | 4.87% |
| 2020 | 1.75% | 1.91% |
| 2019 | 2.76% | 2.86% |
| 2018 | 1.94% | 2.8% |
The market average is the average return for funds of the same risk category, sourced from the Commission for Financial Capability's Sorted website. The fund information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
Umbs Mortpass 6% 07/54
United States Int Fixed Interest AA+
Tba Umbs Single Family 5%
United States Int Fixed Interest AA+
French 2.75% 02/30
France Int Fixed Interest AA-
Gnma Ii 3.5% 11/54
United States Int Fixed Interest AA+
Umbs Mortpass 6.5% 12/53
United States Int Fixed Interest AA+
Japan Bill Zero 06/25
Japan Cash and Equivalents A1
Kingdom Of 3.55% 10/33
Spain Int Fixed Interest A
United States 4.5% 11/54
United States Int Fixed Interest AA+
Nederlandse 2.5% 09/27
Netherlands Int Fixed Interest AAA
United 4.625% 02/55
United States Int Fixed Interest AA+
| Type | Target | Actual |
|---|---|---|
| Cash and Cash Equivalents | 0.0% | 3.31% |
| New Zealand Fixed Interest | 0.0% | 0.01% |
| International Fixed Interest | 100.0% | 96.68% |
| Australasian Equities | 0.0% | 0.0% |
| International Equities | 0.0% | 0.0% |
| Listed Properties | 0.0% | 0.0% |
| Unlisted Properties | 0.0% | 0.0% |
| Other | 0.0% | 0.0% |
| Commodities | 0.0% | 0.0% |
How the money in this fund is invested by asset type.
This information has been sourced from the quarterly data that each fund has filed with Disclose register to 31st March 2025.
